Clinical trial · Interventional
Streamlined Genetic Testing in Prostate Cancer
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The goal of this pilot randomized controlled trial is to evaluate the impact and efficacy of a streamlined genetic education and testing intervention for men with prostate cancer. Eligible men are prostate cancer survivors who meet criteria for genetic counseling referral. After completing a baseline survey, participants (n=120) are randomized to Streamlined Genetic Testing (ST) or Usual Care (UC). Participants in ST are able to review genetic education materials and then proceed directly to genetic testing. Participants in UC will be provided with a referral for standard individual genetic counseling. Two months after randomization all participants will be contacted to complete a follow-up survey.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Prostate Cancer | Malignant Prostate Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Proactive Streamlined Genetic Education and Testing | Behavioral | — | UNRESOLVED |
| Usual Care | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Proactive Streamlined Genetic Education and Testing
- description
- Participants randomized to this arm will proactively receive genetic education print materials and the option to proceed directly with genetic testing.
- interventionNames
- Behavioral: Proactive Streamlined Genetic Education and Testing
- type
- ACTIVE_COMPARATOR
- label
- Usual Care
- description
- Participants in this arm will be sent a referral letter recommending that they schedule a genetic counseling session and providing them with contact information to do so.
- interventionNames
- Behavioral: Usual Care
Primary outcomes (1)
- measure
- Number of Participants Completing Genetic Testing
Eligibility
Eligibility (as posted)
- Sex
- Male
- Minimum age
- 21 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: * Male * Diagnosed with metastatic prostate cancer or Gleason 7+ prostate cancer * Diagnosed between 2010-2020 Exclusion Criteria: * Age 81 or older * Previous cancer genetic counseling or testing * Previously scheduled for cancer genetic counseling or testing * Cannot participate in English * Are not capable of providing informed consent
References
Publications (0)
Data not yet available